Related Experiment Video
Updated: Jun 24, 2026

09:05
Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
Published on: June 29, 2020
DNA methylation analysis on a droplet-in-oil PCR array
Yi Zhang1, Vasudev Bailey, Christopher M Puleo
1Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Lab on a Chip
|April 8, 2009
Summary
This study introduces a user-friendly microfluidic platform for on-chip DNA methylation analysis. The droplet-in-oil system simplifies methylation-specific PCR (MSP) for practical clinical applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- DNA methylation is crucial in gene regulation and disease.
- Microfluidic droplet technologies offer potential for sensitive molecular analysis.
- Existing droplet platforms can be complex for routine clinical use.
Purpose of the Study:
- To develop a simplified, arrayed microfluidic platform for DNA methylation analysis.
- To enable practical clinical applications of droplet-based PCR.
- To demonstrate the utility of the platform for analyzing tumor suppressor gene methylation.
Main Methods:
- On-chip DNA methylation analysis using methylation-specific PCR (MSP).
- A droplet-in-oil microfluidic platform with pre-deposited arrayed primers.
- Utilizing the oil phase for sample actuation and compartmentalization.
- Analysis of p15 and TMS1 tumor suppressor promoter methylation.
Main Results:
- The platform allows for the analysis of minute sample volumes.
- It simplifies sample handling and compartmentalization compared to other droplet systems.
- On-chip methylation assay results for p15 and TMS1 were consistent with standard MSP.
- The platform enables large-scale, arrayed DNA methylation analysis.
Conclusions:
- The droplet-in-oil microfluidic PCR platform is an easy and efficient tool for DNA methylation analysis.
- This technology is suitable for practical, large-scale clinical applications.
- The simplified approach enhances the accessibility of microfluidic droplet technologies.

